Stonepine Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Buy |
205,100
+102,835
| +101% | +$480K | 0.94% | 28 |
|
|
2025
Q1 | $561K | Sell |
102,265
-80,052
| -44% | -$439K | 0.55% | 37 |
|
|
2024
Q4 | $618K | Buy |
+182,317
| New | +$618K | 0.5% | 38 |
|
|
2024
Q2 | – | Sell |
-598,086
| Closed | -$1.32M | – | 31 |
|
|
2024
Q1 | $1.32M | Sell |
598,086
-5,338,914
| -90% | -$11.8M | 1.05% | 15 |
|
|
2023
Q4 | $14M | Buy |
5,937,000
+21,628
| +0.4% | +$50.8K | 6.03% | 6 |
|
|
2023
Q3 | $11M | Buy |
5,915,372
+415,144
| +8% | +$772K | 3.66% | 8 |
|
|
2023
Q2 | $14.4M | Sell |
5,500,228
-3,139,977
| -36% | -$8.23M | 5.2% | 7 |
|
|
2023
Q1 | $14.1M | Sell |
8,640,205
-2,554,984
| -23% | -$4.16M | 4.72% | 6 |
|
|
2022
Q4 | $14.9M | Sell |
11,195,189
-1,732,979
| -13% | -$2.3M | 6.26% | 6 |
|
|
2022
Q3 | $20.2M | Buy |
12,928,168
+1,280,751
| +11% | +$2M | 9.07% | 4 |
|
|
2022
Q2 | $17.9M | Buy |
11,647,417
+3,723,361
| +47% | +$5.73M | 8.35% | 3 |
|
|
2022
Q1 | $20.3M | Buy |
7,924,056
+2,267,683
| +40% | +$5.81M | 8.41% | 3 |
|
|
2021
Q4 | $16.6M | Buy |
+5,656,373
| New | +$16.6M | 7.61% | 3 |
|